Shots: Instituto Butantan to receive $26M upfront, $75M milestones and royalties on sales from Merck. Merck to get clinical data and learnings (utilized for its TV003, dengue vaccine) from Instituto’s development programs to […]readmore
Tags : Dengue Infection